Special Diabetes Program Funding Extended Allowing Critical Type 1 Diabetes Research to Continue

in ,

Special Diabetes Program

The Federal Government has continued its commitment to support diabetes research by providingĀ more thanĀ $75Ā million into the Special Diabetes ProgramĀ (SDP), which drives forward critical research aimed at curing type 1 diabetes (T1D) and improving the lives of those living with the disease today.

The funding, approved by both the House and Senate and signed by the President, extends support for SDP until November 30, 2020.Ā Renewing the SDP is one of JDRFā€™s top legislative priorities,Ā and countlessĀ JDRF advocates have been workingĀ diligentlyĀ for monthsĀ alongside JDRF staff andĀ with our championsĀ in CongressĀ to achieve this milestone.

Funding through the SDP, which is administered by the National Institutes of Health,Ā complementsĀ and expands research driven by JDRF. By leveragingĀ FederalĀ dollars, funding from partners and supporter donations, JDRF accelerates the race to cure T1D and supportsĀ everyone living with the disease today.

ā€œWe are grateful to Congress and the Administration for continuing to acknowledge and support the critical need to cure T1D, which impacts an increasing number of families every year. We look forward to continuing work to further support the T1D community, including ensuring everyone can access affordable insulin, an especially urgent concern in this economic climate,ā€ said Aaron, J. Kowalski, Ph.D., JDRF President and CEO.

This is theĀ fourthĀ SDP extension passed by Congress since September. This extension was included in theĀ FederalĀ economic relief package created in response to the coronavirus pandemic.Ā 

The package also included two additional benefits for the T1D community:

  • Renewed funding for community health centers, where people can access affordable insulin and other prescriptions.Ā 
  • A requirementĀ thatĀ Medicare Part D plansĀ provide up to a 90-day supply ofĀ prescriptionĀ medications, including insulin,Ā if requested by a beneficiary during the COVID-19 emergency period.Ā 

For additional resources aimed at supporting access and payment for insulin and other prescriptions visit jdrf.org/costs.

For additional information and resources about COVID-19, including how to stay healthy and be prepared with extra medications and supplies, visit jdrf.org/coronavirus.